These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21839316)

  • 1. Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment.
    Felsten LM; Alikhan A; Petronic-Rosic V
    J Am Acad Dermatol; 2011 Sep; 65(3):493-514. PubMed ID: 21839316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitiligo surgical, laser, and alternative therapies: a review and case series.
    Wassef C; Lombardi A; Khokher S; Rao BK
    J Drugs Dermatol; 2013 Jun; 12(6):685-91. PubMed ID: 23839187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitiligo: new and emerging treatments.
    Lotti T; Gori A; Zanieri F; Colucci R; Moretti S
    Dermatol Ther; 2008; 21(2):110-7. PubMed ID: 18394085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on skin repigmentation therapies in vitiligo.
    Falabella R; Barona MI
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrathin split-thickness skin grafting followed by narrowband UVB therapy for stable vitiligo: an effective and cosmetically satisfying treatment option.
    Majid I; Imran S
    Indian J Dermatol Venereol Leprol; 2012; 78(2):159-64. PubMed ID: 22421646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo: an update on current pharmacotherapy and future directions.
    Colucci R; Lotti T; Moretti S
    Expert Opin Pharmacother; 2012 Sep; 13(13):1885-99. PubMed ID: 22835073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.
    Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV
    Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
    Saraceno R; Nisticò SP; Capriotti E; Chimenti S
    Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depigmentation Therapies for Vitiligo.
    Grimes PE; Nashawati R
    Dermatol Clin; 2017 Apr; 35(2):219-227. PubMed ID: 28317530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depigmentation therapies in vitiligo.
    Gupta D; Kumari R; Thappa DM
    Indian J Dermatol Venereol Leprol; 2012; 78(1):49-58. PubMed ID: 22199060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitiligo treatment in childhood: a state of the art review.
    Tamesis ME; Morelli JG
    Pediatr Dermatol; 2010; 27(5):437-45. PubMed ID: 20553403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical Therapies for Vitiligo.
    Mohammad TF; Hamzavi IH
    Dermatol Clin; 2017 Apr; 35(2):193-203. PubMed ID: 28317528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repigmentation of Tenacious Vitiligo on Apremilast.
    Huff SB; Gottwald LD
    Case Rep Dermatol Med; 2017; 2017():2386234. PubMed ID: 29234546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes.
    Hossani-Madani A; Halder R
    G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1,000 patients.
    Malakar S; Dhar S
    Dermatology; 1999; 198(2):133-9. PubMed ID: 10325459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening.
    Grau C; Silverberg NB
    Cutis; 2013 May; 91(5):248-52. PubMed ID: 23772431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camouflaging Agents for Vitiligo Patients.
    Hossain C; Porto DA; Hamzavi I; Lim HW
    J Drugs Dermatol; 2016 Apr; 15(4):384-7. PubMed ID: 27050692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser-assisted depigmentation for resistant vitiligo: a retrospective case series with long-term follow-up.
    Boukari F; Lacour JP; Ortonne JP; Bahadoran P; Passeron T
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):374-7. PubMed ID: 23167541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Q-switched laser depigmentation in vitiligo, most effective in active disease.
    Komen L; Zwertbroek L; Burger SJ; van der Veen JP; de Rie MA; Wolkerstorfer A
    Br J Dermatol; 2013 Dec; 169(6):1246-51. PubMed ID: 23909405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitiligo Surgery: Shuffling Melanocytes.
    Nahhas AF; Mohammad TF; Hamzavi IH
    J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S34-S37. PubMed ID: 28941491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.